STANDARD BIOTOOLS INC (LAB)
US34385P1084 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -124.59M | -74.66M | -190.10M | -59.24M | -53.02M | |||
| Depreciation Amortization | 16.82M | 15.18M | 15.03M | 15.57M | 15.92M | |||
| Change In Working Capital | -38.83M | 1.79M | -15.48M | -19.93M | 2.41M | |||
| Interest Paid | 3.29M | 3.82M | 3.49M | 3.15M | 3.09M | |||
| Taxes Paid | 578.00K | 801.00K | 310.00K | 2.09M | 520.00K | |||
| Other non cash items | 3.14M | 14.40M | 101.18M | 19.54M | 19.27M | |||
| OPERATING CASH FLOW | -143.45M | -43.29M | -89.37M | -44.06M | -15.42M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.05M | -2.83M | -3.83M | -13.26M | -12.72M | |||
| Other Investing Activity | 329.38M | 23.07M | -84.30M | 1.32M | 52.69M | |||
| INVESTING CASH FLOW | 324.33M | 20.24M | -88.13M | -11.95M | 39.98M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.45M | -2.08M | 18.16M | 16.34M | 0.00 | |||
| Stock Issued/Repurchased | -38.70M | -4.59M | 225.35M | 1.49M | 22.00M | |||
| Other Financing Activity | -958.00K | -139.00K | -12.76M | -1.87M | -1.14M | |||
| FINANCING CASH FLOW | -49.09M | -6.81M | 230.76M | 15.96M | 20.86M | |||
| Exchange Rate Effect | -284.00K | 34.00K | -400.00K | -20.00K | 390.00K | |||
| CHANGE IN CASH | 131.50M | -29.83M | 52.86M | -40.07M | 45.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -143.45M | -43.29M | -89.37M | -44.06M | -15.42M | |||
| Capital Expenditure | -5.05M | -2.83M | -3.83M | -13.26M | -12.72M | |||
| FREE CASH FLOW | -148.51M | -46.12M | -93.20M | -57.32M | -28.14M | |||
All data in USD